Search

everythinglearnresearchcommunity

for

Search:↓

RHA fillers are effective and safe for treating nasolabial folds in people of color.

5-alpha reductase inhibitors may increase depression risk by 31%, but results vary based on comparison groups.

Higher monocyte counts may predict poor response to adalimumab in hidradenitis suppurativa patients.

Switching JAK inhibitors or using dupilumab may help some alopecia areata patients who don't respond well to initial treatments.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.

Dapsone improved pustular psoriasis in patients who didn't respond to other treatments and is considered a well-tolerated option.

Syphilis treatment resolved hair loss and eye symptoms, highlighting its importance in diagnosing unusual alopecia.

The study found that a specific genetic variation in the TNFα gene is significantly linked to Alopecia Areata in the Jordanian Arab population.

Mycophenolate mofetil is safer and more effective than cyclophosphamide for treating lupus nephritis.

Autoimmune Polyendocrine Syndromes involve specific combinations of autoimmune diseases.

Psoriasis or contact dermatitis can override alopecia areata, allowing hair growth.

Retinoic acid affects male and female muscle energy use and function differently.

5α-reductase inhibitors do not improve survival in oesophageal and gastric cancer patients.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Pincer nails are rare in lupus patients and may be managed conservatively.

JAK inhibitors help regrow hair in alopecia areata, but their long-term safety is still unclear.

Dystonia may be part of PAS-4 and linked to immune issues.

The oral contraceptive alone is the preferred treatment for hirsutism, as adding the GnRH analog showed no significant benefit.

There is no causal relationship between androgenetic alopecia and serum uric acid.

Low DHEA-S levels might be linked to alopecia areata and could be a potential treatment target.

An 18-year-old girl improved with treatment after being diagnosed with both Systemic Lupus Erythematosus and Celiac Disease.

Infliximab may cause hair loss in Crohn's disease patients.

A woman developed psoriasis after taking certolizumab pegol, improving after stopping the drug and starting other treatments.

Higher thyroid antibodies in Hashimoto's thyroiditis are linked to more inflammation and symptoms.

Syphilis should be considered if PLEVA-like symptoms don't improve with treatment.

Women with PCOS had higher SRAGE levels, possibly linked to BMI, not PCOS.

Early recognition and treatment of severe SLE symptoms can improve outcomes.

Both treatments for localized alopecia areata are equally effective.